Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | cefoxitin | 441199 | drug-path |
Shigellosis | 0 | map05131 | cefoxitin | 441199 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | cefoxitin | 441199 | drug-path |
Gap junction | R-HSA-190861 | map04540 | cefoxitin | 441199 | drug-path |
Glioma | Q9NZM4 | map05214 | iopromide | 3736 | drug-path |
Renal cell carcinoma | R-HSA-9794523 | map05211 | iopromide | 3736 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | iopromide | 3736 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | iopromide | 3736 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | iopromide | 3736 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | iopromide | 3736 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | iopromide | 3736 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | iopromide | 3736 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | iopromide | 3736 | drug-path |
ErbB signaling pathway | R-HSA-168638 | map04012 | iopromide | 3736 | drug-path |
Non-small cell lung cancer | R-HSA-5619066 | map05223 | iopromide | 3736 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | iopromide | 3736 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | iopromide | 3736 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | iopromide | 3736 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | iopromide | 3736 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | iopromide | 3736 | drug-path |